Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Freehold Royalties Ltd 2018 Q2 - Results - Earnings Call Slides

2018-08-06 seekingalpha
The following slide deck was published by Freehold Royalties Ltd in conjunction with their 2018 Q2 earnings call.
FRU FRHLF

0
Freehold Royalties Ltd (FRHLF) CEO Thomas Mullane on Q2 2018 Results - Earnings Call Transcript

2018-08-05 seekingalpha
Good morning, ladies and gentlemen. Welcome to the Freehold Royalties Ltd. Second Quarter Conference Call. Please be advised that certain statements on the call constitute forward-looking information. These statements relate to future events, or our expectations for future performance. All statements, other than those of historical facts, may be forward-looking, and we caution the listener.
FRU FRHLF

0
Freehold Royalties Ltd. Strong Growth in Funds from Operations and Second Quarter Results

2018-08-02 globenewswire
CALGARY, Alberta, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced second quarter results for the period ended June 30, 2018.
FRU FRHLF

0
Freehold Royalties Ltd. Declares Dividend for July 2018

2018-07-12 globenewswire
CALGARY, Alberta, July 12, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on August 15, 2018 to shareholders of record on July 31, 2018.
FRU FRHLF

10
This Little Known Oil Stock Has Outperformed The Dividend Aristrocrats

2018-06-29 seekingalpha
Using very little debt Freehold has outperformed most large cap oil stocks even without having downstream operations that some of its large cap brethren have.
FRU BOE XOM DVN FRHLF

0
Freehold Royalties Ltd. Declares Dividend for June 2018

2018-06-12 globenewswire
CALGARY, Alberta, June 12, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on July 16, 2018 to shareholders of record on June 30, 2018.
FRU FRHLF

0
Freehold Royalties' (FRHLF) CEO Tom Mullane on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Please be advised that certain statements on this call constitute forward-looking information. These statements relate to future events or our expectations for future performance. All statements, other than those of historical facts, may be forward-looking and we caution the listener.
FRU FRHLF

0
Freehold Royalties Ltd. Shareholders Approve Resolutions at Annual Meeting

2018-05-10 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced today that all nominees listed in its notice of meeting and information circular dated March 23, 2018, were elected as directors of Freehold at its Annual Meeting of Shareholders held today in Calgary.
FRU FRHLF

0
Freehold Royalties Ltd. Announces Continued Royalty Growth and First Quarter Results

2018-05-09 globenewswire
CALGARY, Alberta, May 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announced first quarter results for the period ended March 31, 2018.
FRU FRHLF

0
Freehold Royalties Ltd. Declares Dividend for April 2018

2018-04-11 globenewswire
CALGARY, Alberta, April 11, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.0525 per common share to be paid on May 15, 2018 to shareholders of record on April 30, 2018.
FRU FRHLF

0
Freehold Royalties Ltd. Announces Investor Day Event

2018-04-09 globenewswire
CALGARY, Alberta, April 09, 2018 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces it will hold its Investor Day in Toronto today beginning at 3:00pm EST. The event will include a formal presentation by Freehold's management and technical teams, showcasing Freehold's 2017 Asset Book.
FRU FRHLF

0
Freehold Royalties Ltd 2017 Q4 - Results - Earnings Call Slides

2018-03-12 seekingalpha
The following slide deck was published by Freehold Royalties Ltd in conjunction with their 2017 Q4 earnings call.
FRU FRHLF

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...